Savior Lifetec Corporation (TPEX:4167)
Taiwan · Delayed Price · Currency is TWD 19.00
-0.20 (-1.04%)
Feb 11, 2026, 1:30 PM CST
Savior Lifetec Market Cap
Savior Lifetec has a market cap or net worth of 5.96 billion as of February 10, 2026. Its market cap has decreased by -5.16% in one year.
Market Cap
5.96B
Enterprise Value
4.57B
Revenue
1.16B
Ranking
n/a
PE Ratio
12.26
Stock Price
19.00
Market Cap Chart
Since December 21, 2012, Savior Lifetec's market cap has increased from 3.75B to 5.96B, an increase of 58.94%. That is a compound annual growth rate of 3.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 5.96B | 4.35% |
| Dec 31, 2025 | 5.71B | -11.78% |
| Dec 31, 2024 | 6.47B | -9.13% |
| Dec 29, 2023 | 7.13B | -9.37% |
| Dec 30, 2022 | 7.86B | 29.94% |
| Dec 30, 2021 | 6.05B | -41.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 6.85B |
| OBI Pharma | 5.93B |
| Sinphar Pharmaceutical | 5.83B |
| CHO Pharma | 5.66B |
| Pharmosa Biopharm | 5.45B |
| Locus Cell | 5.40B |
| Panion & Bf Biotech | 5.34B |
| UnicoCell Biomed | 5.27B |